WallStreetZenWallStreetZen

NASDAQ: OCGN
Ocugen Inc Stock

$0.38-0.01 (-2.56%)
Updated Nov 28, 2023
OCGN Price
$0.38
Fair Value Price
N/A
Market Cap
$96.96M
52 Week Low
$0.35
52 Week High
$1.62
P/E
-1.15x
P/B
1.66x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$75.52M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.28
Operating Cash Flow
-$68M
Beta
1.34
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

OCGN Overview

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OCGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OCGN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OCGN is good value based on its book value relative to its share price (1.66x), compared to the US Biotechnology industry average (5.31x)
P/B vs Industry Valuation
OCGN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OCGN due diligence checks available for Premium users.

Be the first to know about important OCGN news, forecast changes, insider trades & much more!

OCGN News

Valuation

OCGN fair value

Fair Value of OCGN stock based on Discounted Cash Flow (DCF)
Price
$0.38
Fair Value
$0.69
Undervalued by
44.90%
OCGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OCGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.15x
Industry
12.55x
Market
32.56x

OCGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.66x
Industry
5.31x
OCGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OCGN's financial health

Profit margin

Revenue
$0.0
Net Income
-$14.2M
Profit Margin
0%
OCGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$74.7M
Liabilities
$16.3M
Debt to equity
0.28
OCGN's short-term assets ($56.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OCGN's short-term assets ($56.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OCGN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OCGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.7M
Investing
-$3.4M
Financing
-$35.0k
OCGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OCGN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
OCGN$96.96M-2.83%-1.15x1.66x
STTK$97.29M-0.43%-1.02x0.86x
ATOS$97.49M-3.95%-3.24x0.99x
CARM$95.44M-2.67%-0.63x2.06x
GLYC$98.52M+1.32%-2.43x2.12x

Ocugen Stock FAQ

What is Ocugen's quote symbol?

(NASDAQ: OCGN) Ocugen trades on the NASDAQ under the ticker symbol OCGN. Ocugen stock quotes can also be displayed as NASDAQ: OCGN.

If you're new to stock investing, here's how to buy Ocugen stock.

What is the 52 week high and low for Ocugen (NASDAQ: OCGN)?

(NASDAQ: OCGN) Ocugen's 52-week high was $1.62, and its 52-week low was $0.35. It is currently -76.67% from its 52-week high and 9.57% from its 52-week low.

How much is Ocugen stock worth today?

(NASDAQ: OCGN) Ocugen currently has 256,502,434 outstanding shares. With Ocugen stock trading at $0.38 per share, the total value of Ocugen stock (market capitalization) is $96.96M.

Ocugen stock was originally listed at a price of $704.99 in Dec 3, 2014. If you had invested in Ocugen stock at $704.99, your return over the last 8 years would have been -99.95%, for an annualized return of -60.99% (not including any dividends or dividend reinvestments).

How much is Ocugen's stock price per share?

(NASDAQ: OCGN) Ocugen stock price per share is $0.38 today (as of Nov 28, 2023).

What is Ocugen's Market Cap?

(NASDAQ: OCGN) Ocugen's market cap is $96.96M, as of Nov 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ocugen's market cap is calculated by multiplying OCGN's current stock price of $0.38 by OCGN's total outstanding shares of 256,502,434.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.